Feasibility, Engagement, and Usability of a Remote, Smartphone-Based Contingency Management Program as a Treatment Add-On for Patients Who Use Methamphetamine: Single-Arm Pilot Study.

Autor: Hallgren KA; Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, United States., Duncan MH; Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, United States., Iles-Shih MD; Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, United States., Cohn EB; Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, United States., McCabe CJ; Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, United States., Chang YM; Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, United States., Saxon AJ; Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, United States.; Center of Excellence in Substance Addiction Treatment and Education, Veterans Health Administration Puget Sound Health Care System, Seattle, WA, United States.
Jazyk: angličtina
Zdroj: JMIR formative research [JMIR Form Res] 2023 Jul 06; Vol. 7, pp. e47516. Date of Electronic Publication: 2023 Jul 06.
DOI: 10.2196/47516
Abstrakt: Background: In the United States, methamphetamine-related overdoses have tripled from 2015 to 2020 and continue to rise. However, efficacious treatments such as contingency management (CM) are often unavailable in health systems.
Objective: We conducted a single-arm pilot study to evaluate the feasibility, engagement, and usability of a fully remotely delivered mobile health CM program offered to adult outpatients who used methamphetamine and were receiving health care within a large university health system.
Methods: Participants were referred by primary care or behavioral health clinicians between September 2021 and July 2022. Eligibility criteria screening was conducted by telephone and included self-reported methamphetamine use on ≥5 out of the past 30 days and a goal of reducing or abstaining from methamphetamine use. Eligible participants who agreed to take part then completed an initial welcome phase that included 2 videoconference calls to register for and learn about the CM program and 2 "practice" saliva-based substance tests prompted by a smartphone app. Participants who completed these welcome phase activities could then receive the remotely delivered CM intervention for 12 consecutive weeks. The intervention included approximately 24 randomly scheduled smartphone alerts requesting a video recording of themselves taking a saliva-based substance test to verify recent methamphetamine abstinence, 12 weekly calls with a CM guide, 35 self-paced cognitive behavioral therapy modules, and multiple surveys. Financial incentives were disbursed via reloadable debit cards. An intervention usability questionnaire was completed at the midpoint.
Results: Overall, 37 patients completed telephone screenings, with 28 (76%) meeting the eligibility criteria and consenting to participate. Most participants who completed a baseline questionnaire (21/24, 88%) self-reported symptoms consistent with severe methamphetamine use disorder, and most had other co-occurring non-methamphetamine substance use disorders (22/28, 79%) and co-occurring mental health disorders (25/28, 89%) according to existing electronic health records. Overall, 54% (15/28) of participants successfully completed the welcome phase and were able to receive the CM intervention. Among these participants, engagement with substance testing, calls with CM guides, and cognitive behavioral therapy modules varied. Rates of verified methamphetamine abstinence in substance testing were generally low but varied considerably across participants. Participants reported positive opinions about the intervention's ease of use and satisfaction with the intervention.
Conclusions: Fully remote CM can be feasibly delivered within health care settings lacking existing CM programs. Although remote delivery may help reduce barriers to treatment access, many patients who use methamphetamine may struggle to engage with initial onboarding. High rates of co-occurring psychiatric conditions in the patient population may also contribute to uptake and engagement challenges. Future efforts could leverage greater human-to-human connection, more streamlined onboarding procedures, larger incentives, longer durations, and the incentivization of non-abstinence-based recovery goals to increase uptake and engagement with fully remote mobile health-based CM.
(©Kevin A Hallgren, Mark H Duncan, Matthew D Iles-Shih, Eliza B Cohn, Connor J McCabe, Yanni M Chang, Andrew J Saxon. Originally published in JMIR Formative Research (https://formative.jmir.org), 06.07.2023.)
Databáze: MEDLINE